U.S Class(es): 006, 018, 044, 046, 051, 052
Name | Novartis Pharma AG, |
---|---|
Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
Dec-25-2023 | TOTAL INVALIDATION PROCESSED BY THE IB | INNTP | |
Dec-01-2023 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | INTSP | |
Dec-01-2023 | INVALIDATION PROCESSED | INPCP | |
Nov-17-2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | INTRP | |
Mar-17-2023 | CANCELLED SECTION 71 | C71TO | |
Jun-09-2017 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | OPNXP | |
Nov-04-2016 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Oct-13-2016 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Oct-13-2016 | FINAL DISPOSITION PROCESSED | FIMPP | |
Oct-06-2016 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Sep-06-2016 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Jun-21-2016 | PUBLISHED FOR OPPOSITION | PUBOA | |
Jun-01-2016 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
Jun-01-2016 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | OP2RP | |
Jun-01-2016 | NOTICE OF PUBLICATION | NPUBO | |
May-12-2016 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
May-09-2016 | ASSIGNED TO EXAMINER | DOCKD | |
May-03-2016 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Apr-29-2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Apr-28-2016 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Apr-28-2016 | SN ASSIGNED FOR SECT 66A APPL FROM IB | REPRM |